fda on semaglutide The approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced Monday. The once-daily 25 Oral Semaglutide Gets FDA Approval

Ochronosis was first reported in Africa and is usually caused by the long-term use of high concentrations of hydroquinone with inadequate sun protection (Bhattar et al., 2015, Grimes, 2009)

Diabetes Care , 39 (10), 20662073

Simultaneous blockade of NMDA receptors and PARP-1 activity synergistically alleviate immunoexcitotoxicity and bioenergetics in 3-nitropropionic acid intoxicated mice: evidence from memantine and 3-aminobenzamide interventions

Drinking alcohol can increase the risk of low blood sugar (hypoglycemia), which can lead to symptoms like dizziness or confusion

The Impact on Appetite and Weight Loss Interestingly, this side effect may play a role in the drugs effectiveness for weight loss